Geode Capital Management LLC raised its holdings in Quanterix Co. (NASDAQ:QTRX – Free Report) by 2.2% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 858,667 shares of the company’s stock after buying an additional 18,231 shares during the quarter. Geode Capital Management LLC owned about 2.24% of Quanterix worth $11,131,000 at the end of the most recent quarter.
Other hedge funds have also recently made changes to their positions in the company. Allspring Global Investments Holdings LLC boosted its holdings in Quanterix by 11.0% in the second quarter. Allspring Global Investments Holdings LLC now owns 14,261 shares of the company’s stock valued at $188,000 after acquiring an additional 1,417 shares in the last quarter. Hsbc Holdings PLC lifted its position in shares of Quanterix by 34.7% in the 2nd quarter. Hsbc Holdings PLC now owns 12,738 shares of the company’s stock worth $164,000 after purchasing an additional 3,279 shares during the period. Emerald Mutual Fund Advisers Trust boosted its stake in shares of Quanterix by 0.8% during the 3rd quarter. Emerald Mutual Fund Advisers Trust now owns 563,247 shares of the company’s stock valued at $7,300,000 after purchasing an additional 4,406 shares in the last quarter. nVerses Capital LLC purchased a new position in shares of Quanterix during the third quarter valued at about $60,000. Finally, Janney Capital Management LLC raised its stake in Quanterix by 33.6% in the third quarter. Janney Capital Management LLC now owns 23,553 shares of the company’s stock worth $305,000 after buying an additional 5,930 shares in the last quarter. 86.48% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Separately, TD Cowen lifted their price objective on Quanterix from $13.50 to $16.00 and gave the company a “hold” rating in a research report on Wednesday, November 13th.
Quanterix Price Performance
Shares of Quanterix stock opened at $10.63 on Wednesday. Quanterix Co. has a 1 year low of $9.87 and a 1 year high of $29.70. The firm has a market cap of $409.51 million, a price-to-earnings ratio of -10.12 and a beta of 1.30. The company has a 50-day moving average of $12.16 and a 200 day moving average of $12.77.
Quanterix Profile
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.
Featured Stories
- Five stocks we like better than Quanterix
- What is an Earnings Surprise?
- 3 Stocks Helping to Bring AI to Healthcare
- Where Do I Find 52-Week Highs and Lows?
- 3 Stocks Ringing in The New Year With Large Buyback Announcements
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Why 2024 Was Great for Stocks—and Why 2025 Could Be Even Better
Want to see what other hedge funds are holding QTRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quanterix Co. (NASDAQ:QTRX – Free Report).
Receive News & Ratings for Quanterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quanterix and related companies with MarketBeat.com's FREE daily email newsletter.